BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.90
-0.18 (-1.79%)
At close: Sep 5, 2025, 4:00 PM
10.23
+0.33 (3.33%)
After-hours: Sep 5, 2025, 7:59 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $855.86 million as of September 5, 2025. Its market cap has increased by 259.22% in one year.
Market Cap
855.86M
Enterprise Value
727.29M
1-Year Change
259.22%
Ranking
Category
Stock Price
$9.90
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $855.86M, an increase of 2,139.73%. That is a compound annual growth rate of 622.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 855.86M | 246.72% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |